BrainsWay’s treatment platform is based on a unique breakthrough technology called Deep TMS, which can reach significant depth and breadth of the brain and produce broad stimulation and functional modulation of targeted brain areas.
The treatment features unique, patented coils that are fitted into a helmet, which is secured snugly to the patient’s head during the treatment. BrainsWay’s therapy has been utilized in over 60 clinical trials worldwide. In the U.S., the Company’s device has been FDA cleared for the treatment of major depressive disorder (MDD) since 2013 and is now FDA cleared (De-Novo) for the treatment of Obsessive Compulsive Disorder (OCD).
Major Depressive Disorder is a neuropsychiatric disorder that is expressed in emotional, physiological and behavioral effects.
Read more
BrainsWay Introduces the First FDA Cleared (De-Novo) Non-invasive Medical Device for the Treatment of OCD.
Read more
Tobacco smoking is the leading cause of preventable death in developed countries.
Read more
Anti-psychotic medications are often effective for the positive symptoms of schizophrenia
Read more
Post-traumatic stress disorder (PTSD) is an extreme anxiety response to a life-threatening situation
Read more
A brain stroke is the loss of brain function due to a disturbance in the blood supply to the brain.
Read more
Parkinson's disease is a degenerative disorder of the central nervous system
Read more
Multiple Sclerosis (MSc) is an inflammatory demyelinating condition of the central nervous system
Read more
Neuropathy is common in the diabetic population, affecting approximately 50% of patients with long-lasting diseases.
Read more
Bipolar disorder, also known as manic-depressive illness
Read more
Autism is a complex developmental disability that typically appears during the first three years of life
Read more
Alzheimer's disease is a major cause of severe cognitive decline in the aged.
Read more